Latest Conference Articles

Dr Anchalee Avihingsanon: ALLIANCE Trial Findings Are Meaningful for HIV/HBV Coinfection

Dr Anchalee Avihingsanon: ALLIANCE Trial Findings Are Meaningful for HIV/HBV Coinfection

July 29th 2022, 8:04pm

AIDS

The ALLIANCE trial is the first randomized blinded trial to investigate tenofovir alafenamide vs tenofovir disoproxil fumarate in treatment-naive individuals who have comorbid HIV/hepatitis B virus (HBV) infection.

After Transplant, City of Hope Patient in Long-term Remission From HIV and Leukemia

After Transplant, City of Hope Patient in Long-term Remission From HIV and Leukemia

July 27th 2022, 2:00pm

City of Hope

City of Hope has announced that a patient living with HIV, who received a stem cell transplant from an unrelated donor to treat acute myelogenous leukemia, has been in remission from both diseases since 2019.

Dr Debra Patt on Capturing the HER2-Low Population

Dr Debra Patt on Capturing the HER2-Low Population

July 24th 2022, 2:16pm

ASCO: American Society of Clinical Oncology

Understanding that patients who are HER2-low are different from patients who are HER2-positive and -negative means having the right way to evaluate and identify these patients, explained Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.

Dr Sabin Dang Outlines the Additional Practice Burdens of Prior Authorizations

Dr Sabin Dang Outlines the Additional Practice Burdens of Prior Authorizations

July 17th 2022, 1:07pm

ASRS: Annual Scientific Meeting of the American Society of Retina Specialists

While prior authorizations are put in place to ensure appropriate use of expensive therapies, they create a substantial burden for clinicians and patients, said Sabin Dang, MD, ophthalmologist with The Retina Institute.

ASRS Posters Review Long-term Visual Outcomes, Treatment Burden of Anti-VEGF Therapies

ASRS Posters Review Long-term Visual Outcomes, Treatment Burden of Anti-VEGF Therapies

July 16th 2022, 7:00pm

ASRS: Annual Scientific Meeting of the American Society of Retina Specialists

Posters presented at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting evaluated the association between long-term visual acuity outcomes and use of anti–vascular endothelial growth factor (VEGF) therapy, as well as patient and caregiver experience with ant-VEGF.

Identifying Long-term Treatment Patterns of Anti-VEGF for DME and the Ideal Dosing Paradigm

Identifying Long-term Treatment Patterns of Anti-VEGF for DME and the Ideal Dosing Paradigm

July 16th 2022, 4:36pm

ASRS: Annual Scientific Meeting of the American Society of Retina Specialists

While anti–vascular endothelial growth factor (VEGF) therapy is the first-line treatment for diabetic macular edema (DME), a majority of patients discontinue therapy after 6 months and there is no consensus on the ideal dosing paradigm.

Technology Allows for Earlier Detection of Eye Conditions

Technology Allows for Earlier Detection of Eye Conditions

July 15th 2022, 7:50pm

ASRS: Annual Scientific Meeting of the American Society of Retina Specialists

Although technology is allowing for earlier detection of eye conditions, lack of reimbursement and insurance coverage remain major barriers to widespread use, explained speakers at the American Society of Retina Specialists 40th Annual Scientific Meeting.

Dr Parisa Emami-Naeni Reviews Remote Retinal Imaging During the Pandemic

Dr Parisa Emami-Naeni Reviews Remote Retinal Imaging During the Pandemic

July 15th 2022, 6:24pm

ASRS: Annual Scientific Meeting of the American Society of Retina Specialists

At the beginning of the pandemic, remote retinal imaging declined sharply due to a recommendation to stop nonessential eye care services in the first months of 2020, said Parisa Emami-Naeni, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.

Dr Paul Hahn Reviews Preferences of US vs International Retina Specialists

Dr Paul Hahn Reviews Preferences of US vs International Retina Specialists

July 15th 2022, 6:20pm

ASRS: Annual Scientific Meeting of the American Society of Retina Specialists

Every year, the American Society of Retina Specialists releases the results of its latest Preferences and Trends Survey at the annual meeting. This year, the survey highlighted some surprising differences between US and international retina specialists, including off-label medication use and what drives drug choices for patients, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

Transformative Technology Is Driving Change in Retina Care Delivery

Transformative Technology Is Driving Change in Retina Care Delivery

July 15th 2022, 1:31pm

ASRS: Annual Scientific Meeting of the American Society of Retina Specialists

The retina space is evolving due to new technology that is changing the way specialists deliver care, whether that means offering the ability to do new procedures in the office or providing more virtual or hybrid care.